LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Clinical trials for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug tested for hard-to-treat blood cancers
Disease control CompletedThis early-phase study tested an experimental drug called JNJ-75348780 in 147 people with two types of blood cancer (non-Hodgkin lymphoma and chronic lymphocytic leukemia) that had returned or stopped responding to other treatments. The drug is designed to help the immune system …
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 09:44 UTC
-
New pill shows promise for hard-to-treat blood cancers in chinese patients
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma whose cancer had returned or not responded to prior treatments. The main goal was to see how many patients had their tumors s…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a combination of three drugs—ibrutinib, fludarabine, and pembrolizumab—in 15 people with high-risk or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if the combination could achieve a complete resp…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 26, 2026 09:32 UTC
-
No chemo needed: new drug combo shows promise for CLL patients
Disease control CompletedThis study tested a chemotherapy-free treatment for people with previously untreated B-cell chronic lymphocytic leukemia (CLL). It combined two targeted drugs, ibrutinib and obinutuzumab, to control the disease. The goal was to see if this approach could reduce cancer cells to ve…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 22, 2026 14:03 UTC